UNSPSC 51434201: Bietaserpine

This classification denotes an antihypertensive agent with the molecular formula C39H53N3O9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0P5B94FVD5, chemically known as 3-beta,20-alpha-yohimban-16-beta-carboxylic acid, 1-(2-(diethylamino)ethyl)-18-beta-hydroxy-11,17-alpha-dimethoxy-, methyl ester, 3,4,5-trimethoxybenzoate (ester) but generally known as bietaserpine, which bears US NIH Compound Identifier 65518. Bietaserpine most often comes in base and bitartrate forms.

UNSPSC 51434201 Bietaserpine, a Commodity code, encompasses emergency and critical-care pharmaceuticals that state and local governments—particularly fire rescue departments, public health agencies, and multistate purchasing cooperatives—procure through competitive sealed bidding and cooperative purchasing agreements. Recent solicitations show state and local buyers acquiring specific advanced life support medications (epinephrine, adenosine, labetalol, diltiazem) and generic multi-source pharmaceuticals through established wholesaler networks, with contracts typically requiring cGMP certification, FDA compliance, expiration-date minimums of six to nine months, and comprehensive safety documentation including Safety Data Sheets and accessibility conformance reporting. The issuing bodies span municipal fire departments (Tampa Fire Rescue via the City of Tampa's Purchasing Department), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state and local facilities in Minnesota and Oregon). Solicitations emphasize supplier reliability, direct wholesaler relationships, and compliance with drug supply chain security standards, with some opportunities including small local business enterprise set-asides or discounts.

Activity concentrates in Florida, Texas, and Minnesota, with the most recent competitive opportunity being the City of Tampa's sealed-bid procurement (Bid No. 26-P-00188, due April 8, 2026, estimated value $40,000) for four specific advanced life support medication line items for Tampa Fire Rescue, awarded to the lowest responsive bidder with a one-year term and two one-year renewal options. The Minnesota Multistate Cooperative Purchasing Alliance issued an RFP (S1070000015802, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers, with contract term of two years and optional extensions, establishing standing-offer agreements across participating state and local facilities. The Texas Health and Human Services Commission issued an RFI (HHS0017013, closed April 3, 2026) exploring direct-to-manufacturer prescription fulfillment capabilities outside traditional PBM and GPO channels, signaling exploratory interest in supply-chain alternatives for future formal procurements.